Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth

Journal of Thoracic Oncology

Volumn 3, Issue 11, 2008, Pages 1245-1250

  Hiramatsu, Miyako ^a,b   Inagaki, Takuya ^a   Inagaki, Tomoya ^a   Matsui, Yoshio ^a   Satoh, Yukitoshi ^a   Okumura, Sakae ^a   Ishikawa, Yuichi ^c   Miyaoka, Etsuo ^d   Nakagawa, Ken ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Follow up; Ground glass; Lung Adenocarcinoma; Thin section CT

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER GROWTH; CANCER RISK; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUND GLASS OPACITY; GROUPS BY AGE; HUMAN; JAPAN; LUNG CANCER; LUNG LESION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS; LUNG; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58949092009     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318189f526     Document Type: Article

References (28)

1. Henschke CI, McCauley DI, Yankelvitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
2. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with a mobile spiral computed tomography scanner. Lancet 1998;351:1242- 1245.
3. Austin JHM, Muller N, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200:327-331.
4. Collins J, Stern EJ. Ground-glass opacity at CT: The ABCs. Am J Roentgenol 1997;169:355-367.
5. Henschke CI, Shaham D, Yankelevitz DF, et al. CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imaging 2006;30:11-15.
6. Nakajima R, Yokose T, Kakinuma R, et al. Localized ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assist Tomogr 2002;26:323-329.
7. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002;121:1464-1467.
8. Jang HJ, Lee KS, Kwon OJ, et al. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology 1996;199:485-488.
9. Kushihashi T, Munechika H, Ri K, et al. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology 1994;193:789-793.
10. Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469-476.
11. Travis WD, Bambilla E, HK Muller-Hermelink, CC Harris. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon (France): IARC, 2004.
12. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling times. Am J Roentgenol 2000;174:763-768.
13. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-1259.
14. Japan Lung Cancer Society, (Eds). General Rule for Clinical and Pathological Record of Lung Cancer. 6th ed. Tokyo: Kanehara Shuppan, 2003 (In Japanese).
15. New York Early Lung Cancer Action Project Investigators. CT screening for lung cancer: diagnosis resulting from the New York Early Lung Cancer Action Project. Radiology 2007;243:239-249.
16. New York Early Lung Cancer Action Project [IELCAP Web site]. Available at: http://www.ielcap.orf/ielcap2.pdf. Accessed August 1, 2007.
17. Libby DM, Smith JP, Aktorki NK, et al. Managing the small pulmonary nodule discovered by CT. Chest 2007;125:1522-1529.
18. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. Am J Roentgenol 2003;180:817-826.
19. Kitamura H, Kameda Y, Nakamura N, et al. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloal-veolar lung carcinoma. Am J Pathol 1995;146:876-887.
20. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure Ground Glass Opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73:386-393.
21. Ohta R, Yamashita M, Nakata M, et al. Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg 2005;79:e1-e2.
22. van Bodegom PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: importance of long term follow up. Thorax 1989;44:788-793.
23. Verhagen AF, Tavilla G, van de Wal HJ, et al. Multiple primary lung cancers. Thorac Cardiovasc Surg 1994;42:40-44.
24. Rosengart TK, Martini N, Ghosn P, et al. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg 1991;52:773-779.
25. Okada M, Tsubota N, Yoshimura M, et al. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998;115: 836-840.
26. Antakli T, Schaefer RF, Rutherford JE, et al. Second primary lung cancer. Ann Thorac Surg 59:863-866, 1995; discussion 867.
27. Matsuzoe D, Hideshima T, Ohshima K, et al. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer 1999;79:1549-1552.
28. Osaki T, Oyama T, Takenoyama M, et al. Assessment of prognosis and p53 mutations in patients with multiple tumors of the lung; intrapulmo-nary metastasis or double primary cancers? Kyobu Geka 2002;55:25-29 (Article in Japanese).